These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 29378415)
1. Severe Toxicity in Nonhuman Primates and Piglets with Systemic High-Dose Administration of Adeno-Associated Virus Serotype 9-Like Vectors: Putting Patients First. Flotte TR; Büning H Hum Gene Ther; 2018 Mar; 29(3):283-284. PubMed ID: 29378415 [No Abstract] [Full Text] [Related]
2. Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN. Hinderer C; Katz N; Buza EL; Dyer C; Goode T; Bell P; Richman LK; Wilson JM Hum Gene Ther; 2018 Mar; 29(3):285-298. PubMed ID: 29378426 [TBL] [Abstract][Full Text] [Related]
3. Adeno-associated Vector Toxicity-To Be or Not to Be? Büning H; Schmidt M Mol Ther; 2015 Nov; 23(11):1673-1675. PubMed ID: 26606658 [No Abstract] [Full Text] [Related]
7. Delivery of alpha- and beta-sarcoglycan by recombinant adeno-associated virus: efficient rescue of muscle, but differential toxicity. Dressman D; Araishi K; Imamura M; Sasaoka T; Liu LA; Engvall E; Hoffman EP Hum Gene Ther; 2002 Sep; 13(13):1631-46. PubMed ID: 12228018 [TBL] [Abstract][Full Text] [Related]
8. How safe is a popular gene therapy vector? Kaiser J Science; 2020 Jan; 367(6474):131. PubMed ID: 31919200 [No Abstract] [Full Text] [Related]
9. Effect of serotype 5 adenoviral and serotype 2 adeno- associated viral vector-mediated gene transfer to salivary glands on the composition of saliva. Wang J; Voutetakis A; Mineshiba F; Illei GG; Dang H; Yeh CK; Baum BJ Hum Gene Ther; 2006 Apr; 17(4):455-63. PubMed ID: 16610933 [TBL] [Abstract][Full Text] [Related]
10. Impact of AAV Capsid-Specific T-Cell Responses on Design and Outcome of Clinical Gene Transfer Trials with Recombinant Adeno-Associated Viral Vectors: An Evolving Controversy. Ertl HCJ; High KA Hum Gene Ther; 2017 Apr; 28(4):328-337. PubMed ID: 28042943 [TBL] [Abstract][Full Text] [Related]
11. Gene therapy with novel adeno-associated virus vectors substantially diminishes atherosclerosis in a murine model of familial hypercholesterolemia. Lebherz C; Gao G; Louboutin JP; Millar J; Rader D; Wilson JM J Gene Med; 2004 Jun; 6(6):663-72. PubMed ID: 15170737 [TBL] [Abstract][Full Text] [Related]
12. FDA statement regarding the use of adeno-associated virus reference standard materials. Gavin DK Hum Gene Ther Methods; 2015 Feb; 26(1):3. PubMed ID: 25679057 [No Abstract] [Full Text] [Related]
13. Gene therapy of the central nervous system: general considerations on viral vectors for gene transfer into the brain. Serguera C; Bemelmans AP Rev Neurol (Paris); 2014 Dec; 170(12):727-38. PubMed ID: 25459120 [TBL] [Abstract][Full Text] [Related]